Td Waterhouse Canada Inc. Bria Cell Therapeutics Corp. Call Options Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding BCTX
# of Institutions
1Shares Held
1Call Options Held
0Put Options Held
0About BriaCell Therapeutics Corp.
- Ticker BCTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,518,000
- Market Cap $11.3M
- Description
- BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...